AI English summary of an SEC filing — figures as filed
Humana said the expected date for Bruce D. Broussard to step down as Chief Executive Officer and for James A. Rechtin to become President and Chief Executive Officer is July 1, 2024. The transition was first announced on October 11, 2023.
Key points
AI summaryHumana said the expected date for Bruce D. Broussard to step down as Chief Executive Officer and for James A. Rechtin to become President and Chief Executive Officer is July 1, 2024. The transition was first announced on October 11, 2023.
Under the agreement dated May 13, 2024, the company said Broussard will provide strategic advisory services after the Transition Date until March 1, 2025, and will then move to the variable staffing pool (temporary worker status) until March 1, 2026.
The company said that during the VSP Period, Broussard will not receive a salary and will be paid an hourly rate only for work performed for the company, not for The Humana Foundation. The company also said he will receive no additional compensation or benefits beyond continued vesting of equity, and will not receive severance benefits under the Executive Severance Policy.
The company said Broussard is expected to resign from the Board of Directors and Rechtin is expected to be elected to the board, both effective July 1, 2024. The press release said Rechtin has more than 22 years of healthcare experience and previously served as President and CEO of Envision Healthcare.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
CEO transition expected on July 1, 2024
Humana said the expected date for Bruce D. Broussard to step down as Chief Executive Officer and for James A. Rechtin to become President and Chief Executive Officer is July 1, 2024. The transition was first announced on October 11, 2023.
Source · Based on the filing body and exhibits
Terms of Broussard's agreement
Under the agreement dated May 13, 2024, the company said Broussard will provide strategic advisory services after the Transition Date until March 1, 2025, and will then move to the variable staffing pool (temporary worker status) until March 1, 2026.
Source · Based on the filing body and exhibits
VSP Period pay and exclusion from Executive Severance Policy
The company said that during the VSP Period, Broussard will not receive a salary and will be paid an hourly rate only for work performed for the company, not for The Humana Foundation. The company also said he will receive no additional compensation or benefits beyond continued vesting of equity, and will not receive severance benefits under the Executive Severance Policy.
Source · Based on the filing body and exhibits
Board changes and Rechtin's background
The company said Broussard is expected to resign from the Board of Directors and Rechtin is expected to be elected to the board, both effective July 1, 2024. The press release said Rechtin has more than 22 years of healthcare experience and previously served as President and CEO of Envision Healthcare.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…